PH domain-mediated autoinhibition and oncogenic activation of Akt

Area of Science:

• Biochemistry
• Molecular Biology
• Structural Biology

Background:

• Akt (Protein Kinase B) is a crucial Ser/Thr kinase regulating metabolism and cancer.
• Akt activity is controlled by an autoinhibitory interaction between its pleckstrin homology (PH) domain and kinase domain.
• The oncogenic E17K Akt mutant highlights the importance of understanding Akt regulation.

Purpose of the Study:

• To investigate the structural and functional impact of mutations on Akt autoinhibition.
• To elucidate the molecular mechanisms underlying Akt conformational control.
• To provide mechanistic insights into oncogenic Akt activation.

Main Methods:

• Site-directed mutagenesis (R86A Akt).
• Structural analysis (X-ray crystallography).
• Biochemical assays to assess protein-protein interactions and kinase activity.

Main Results:

• The R86A mutation unexpectedly enhances Akt autoinhibition by increasing PH domain-kinase domain affinity.
• A critical interaction network involving Arg86, Glu17, and Tyr18 was identified.
• This network is essential for maintaining Akt's autoinhibited conformation and regulating its activity.

Conclusions:

• The R86A mutation provides a novel tool to study Akt autoinhibition.
• Understanding the Arg86-Glu17-Tyr18 network is key to comprehending Akt regulation.
• These findings illuminate the molecular basis of oncogenic E17K Akt activation and offer potential therapeutic targets.